"Dextroamphetamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
Descriptor ID |
D003913
|
MeSH Number(s) |
D02.092.471.683.152.110.200
|
Concept/Terms |
Dextroamphetamine- Dextroamphetamine
- Dexamphetamine
- Dexamfetamine
- dextro-Amphetamine
- dextro Amphetamine
- d-Amphetamine
- d Amphetamine
Dextroamphetamine Sulfate- Dextroamphetamine Sulfate
- Sulfate, Dextroamphetamine
- Dextro-Amphetamine Sulfate
- Dextro Amphetamine Sulfate
- d-Amphetamine Sulfate
- d Amphetamine Sulfate
|
Below are MeSH descriptors whose meaning is more general than "Dextroamphetamine".
Below are MeSH descriptors whose meaning is more specific than "Dextroamphetamine".
This graph shows the total number of publications written about "Dextroamphetamine" by people in this website by year, and whether "Dextroamphetamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dextroamphetamine" by people in Profiles.
-
Day J, Yust-Katz S, Cachia D, Wefel J, Tremont Lukats IW, Bulbeck H, Rooney AG. Interventions for the management of fatigue in adults with a primary brain tumour. Cochrane Database Syst Rev. 2022 09 12; 9:CD011376.
-
Bonasera SJ, Schenk AK, Luxenberg EJ, Tecott LH. A novel method for automatic quantification of psychostimulant-evoked route-tracing stereotypy: application to Mus musculus. Psychopharmacology (Berl). 2008 Mar; 196(4):591-602.
-
Connor DF, Benjamin S, Ozbayrak KR. Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment. J Am Acad Child Adolesc Psychiatry. 1995 Nov; 34(11):1490-4.
-
Drachman DA. Memory and cognitive function in man: does the cholinergic system have a specific role? Neurology. 1977 Aug; 27(8):783-90.